Using MRI to measure lung fluid in patients with acute heart failure
Official title: MRI Assessment of Pulmonary Edema in Acute Heart Failure
Run by University of Alberta · NCT03999138 · Data updated 2026-11-12
This study is testing if using MRI can help measure lung fluid in people with acute heart failure to see if it can improve treatment and predict their chances of coming back to the hospital or facing serious issues later on.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | University of Alberta Academic / other |
| Locations | 2 sites (Edmonton, Alberta and 1 other locations) |
| Status | Recruiting |
| Started | January 2, 2019 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | May 8, 2026 |
| Trial ID | NCT03999138 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older who are being treated for acute heart failure and are within 48 hours of starting diuretic therapy.
✕Probably not a fit
Patients who are critically ill or have contraindications to MRI will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to improve the accuracy of measuring pulmonary edema, or fluid in the lungs, in patients with acute heart failure (AHF) using MRI technology. Researchers will assess lung water levels at the time of hospital admission and discharge to track changes during treatment. Additionally, the study will evaluate whether these measurements can predict the risk of hospital readmission or mortality related to heart failure. A total of 300 patients will be recruited from multiple centers, and their medical records will be followed for up to five years post-hospitalization.
Why it matters
Potential benefit: If successful, this study could lead to better management of acute heart failure by providing more accurate assessments of lung fluid levels, potentially improving patient outcomes.
How similar studies have gone: While the use of MRI in this context is relatively novel, similar studies have shown promise in improving diagnostic accuracy for heart failure-related conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years of age or older and willing/able to provide informed consent * patients being treated for acute heart failure (including those patients with both reduced and preserved ejection fraction) * patients receiving medical therapy for pulmonary edema by current standard of care (including oral or IV diuretics) * patients identified within 48 hours of initiation of medical therapy for pulmonary edema, defined as the time of first diuretic (IV or PO) or escalation of existing diuretic therapy administered within the ED or hospital Exclusion Criteria: * contraindication to MRI * patient too critically ill/unstable as per the clinical care team for transport to MRI scanner within the required scanning window * moderate to severe dementia
Where it's running
-
University of Ottawa Heart Institute
Ottawa, Ontario, Canada Recruiting -
University of Alberta
Edmonton, Alberta, Canada Active not recruiting
Study contacts
- Study coordinator: Ian Paterson, MD
- Email: DPaterson@ottawaheart.ca
- Phone: 613-696-7267
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Infusion of furosemide to see if a loading infusion helps remove fluid better in acute heart failure
This study tests whether giving furosemide as a continuous infusion with a loading dose is better at removing excess fluid than giving it as bolus injections in adults with acute heart failure.
-
Characterizing phenotypes of acute heart failure
This project will try to see if heart function measures, imaging features (radiomics), and blood biomarkers can predict outcomes for adults hospitalized with acute heart failure, including cardiogenic shock.
-
Early finerenone treatment for hospitalized adults with acute heart failure and LVEF ≥40%
This trial will test whether starting finerenone early during hospitalization helps adults with acute heart failure who have a left ventricular ejection fraction of 40% or higher.
-
Intensive GDMT optimization for women after heart failure hospitalization
This study tests whether rapidly increasing and closely monitoring heart failure meds in women after hospitalization can reduce death or readmission within a year.
-
Using intra‑abdominal pressure and bedside ultrasound to guide decongestive treatment in heart failure
This trial will test whether using bladder pressure (intra‑abdominal pressure) measurements together with bedside ultrasound to guide IV loop diuretics helps people hospitalized with acute heart failure get rid of excess fluid more effectively than usual care.
-
Investigating heart issues in COPD patients during hospital stays
This study is trying to see if sudden worsening of COPD can cause heart problems in hospitalized patients and how it affects their recovery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.